C.J. Kuo

826 total citations
22 papers, 640 citations indexed

About

C.J. Kuo is a scholar working on Organic Chemistry, Physiology and Molecular Biology. According to data from OpenAlex, C.J. Kuo has authored 22 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 13 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in C.J. Kuo's work include Carbohydrate Chemistry and Synthesis (14 papers), Lysosomal Storage Disorders Research (13 papers) and Trypanosoma species research and implications (7 papers). C.J. Kuo is often cited by papers focused on Carbohydrate Chemistry and Synthesis (14 papers), Lysosomal Storage Disorders Research (13 papers) and Trypanosoma species research and implications (7 papers). C.J. Kuo collaborates with scholars based in Netherlands, United Kingdom and Singapore. C.J. Kuo's co-authors include Herman S. Overkleeft, Johannes M. F. G. Aerts, Marta Artola, Bogdan I. Florea, G.J. Davies, Jeroen D. C. Codée, Liang Wu, Gijsbert A. van der Marel, Wouter W. Kallemeijn and Rolf G. Boot and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Chemical Communications.

In The Last Decade

C.J. Kuo

22 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.J. Kuo Netherlands 16 364 358 195 134 79 22 640
Kah‐Yee Li Netherlands 9 349 1.0× 437 1.2× 176 0.9× 103 0.8× 57 0.7× 9 574
Xu He Canada 13 349 1.0× 101 0.3× 119 0.6× 40 0.3× 50 0.6× 23 553
Xuequan Lu United States 17 900 2.5× 215 0.6× 95 0.5× 172 1.3× 133 1.7× 24 1.1k
Thomas Lanyon‐Hogg United Kingdom 16 644 1.8× 129 0.4× 39 0.2× 121 0.9× 40 0.5× 28 809
Qing‐Xin Hua United States 16 647 1.8× 89 0.2× 81 0.4× 142 1.1× 28 0.4× 19 826
Tineke Voorn-Brouwer Netherlands 15 904 2.5× 146 0.4× 134 0.7× 106 0.8× 91 1.2× 16 1.0k
Manju Basu United States 13 577 1.6× 254 0.7× 92 0.5× 70 0.5× 21 0.3× 35 711
Andrea Gunawan United States 19 720 2.0× 152 0.4× 79 0.4× 57 0.4× 31 0.4× 29 987
Todd L. Graybill United States 16 414 1.1× 351 1.0× 31 0.2× 55 0.4× 68 0.9× 29 818
Sybrin P. Schröder Netherlands 11 227 0.6× 259 0.7× 52 0.3× 46 0.3× 21 0.3× 19 414

Countries citing papers authored by C.J. Kuo

Since Specialization
Citations

This map shows the geographic impact of C.J. Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Kuo more than expected).

Fields of papers citing papers by C.J. Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Kuo. The network helps show where C.J. Kuo may publish in the future.

Co-authorship network of co-authors of C.J. Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of C.J. Kuo. A scholar is included among the top collaborators of C.J. Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J. Kuo. C.J. Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liefhebber, Jolanda M.P., Giso Brasser, Roelof Ottenhoff, et al.. (2024). Preclinical efficacy and safety of adeno-associated virus 5 alpha-galactosidase: A gene therapy for Fabry disease. Molecular Therapy — Methods & Clinical Development. 32(4). 101375–101375. 5 indexed citations
2.
Kuo, C.J., Qin Su, Adrianus M. C. H. van den Nieuwendijk, et al.. (2023). The development of a broad-spectrum retaining β-exo-galactosidase activity-based probe. Organic & Biomolecular Chemistry. 21(38). 7813–7820. 4 indexed citations
3.
Kuo, C.J., Liang Wu, V. Roig-Zamboni, et al.. (2022). 1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease. Journal of the American Chemical Society. 144(32). 14819–14827. 17 indexed citations
4.
Aten, Jan, et al.. (2022). HEPES‐buffering of bicarbonate‐containing culture medium perturbs lysosomal glucocerebrosidase activity. Journal of Cellular Biochemistry. 123(5). 893–905. 4 indexed citations
5.
McGregor, Nicholas G. S., C.J. Kuo, Wendy A. Offen, et al.. (2021). Synthesis of broad-specificity activity-based probes for exo-β-mannosidases. Organic & Biomolecular Chemistry. 20(4). 877–886. 11 indexed citations
6.
Armstrong, Zachary, Marta Artola, Bogdan I. Florea, et al.. (2021). Activity-Based Protein Profiling of Retaining α-Amylases in Complex Biological Samples. Journal of the American Chemical Society. 143(5). 2423–2432. 25 indexed citations
7.
Su, Qin, Sybrin P. Schröder, María Pía Ferraz, et al.. (2021). Xylose‐Configured Cyclophellitols as Selective Inhibitors for Glucocerebrosidase. ChemBioChem. 22(21). 3090–3098. 6 indexed citations
8.
Artola, Marta, C.J. Kuo, Gijsbert A. van der Marel, et al.. (2019). Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish. Journal of the American Chemical Society. 141(10). 4214–4218. 31 indexed citations
9.
Mirzaian, Mina, C.J. Kuo, Marta Artola, et al.. (2019). Role of μ-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish. Journal of Lipid Research. 60(11). 1851–1867. 26 indexed citations
10.
Aerts, Johannes M. F. G., et al.. (2019). Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease. Current Opinion in Chemical Biology. 53. 204–215. 48 indexed citations
11.
Kuo, C.J., Wouter W. Kallemeijn, Mina Mirzaian, et al.. (2019). In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity‐based protein profiling. FEBS Journal. 286(3). 584–600. 42 indexed citations
12.
Wu, Liang, Jianbing Jiang, Yi Jin, et al.. (2017). Activity-based probes for functional interrogation of retaining β-glucuronidases. Nature Chemical Biology. 13(8). 867–873. 84 indexed citations
13.
Schröder, Sybrin P., Wouter W. Kallemeijn, C.J. Kuo, et al.. (2017). Towards broad spectrum activity-based glycosidase probes: synthesis and evaluation of deoxygenated cyclophellitol aziridines. Chemical Communications. 53(93). 12528–12531. 29 indexed citations
14.
Liu, Bing, Richard J. B. H. N. van den Berg, Adrianus M. C. H. van den Nieuwendijk, et al.. (2017). A Fluorescence Polarization Activity-Based Protein Profiling Assay in the Discovery of Potent, Selective Inhibitors for Human Nonlysosomal Glucosylceramidase. Journal of the American Chemical Society. 139(40). 14192–14197. 56 indexed citations
15.
Artola, Marta, Liang Wu, María Pía Ferraz, et al.. (2017). 1,6-Cyclophellitol Cyclosulfates: A New Class of Irreversible Glycosidase Inhibitor. ACS Central Science. 3(7). 784–793. 45 indexed citations
16.
Kuo, C.J., Eline van Meel, Wouter W. Kallemeijn, et al.. (2017). Activity-Based Probes for Glycosidases: Profiling and Other Applications. Methods in enzymology on CD-ROM/Methods in enzymology. 598. 217–235. 18 indexed citations
17.
Jiang, Jianbing, C.J. Kuo, Liang Wu, et al.. (2016). Detection of Active Mammalian GH31 α-Glucosidases in Health and Disease Using In-Class, Broad-Spectrum Activity-Based Probes. ACS Central Science. 2(5). 351–358. 48 indexed citations
18.
Li, Nan, C.J. Kuo, Hans van den Elst, et al.. (2013). Relative quantification of proteasome activity by activity-based protein profiling and LC-MS/MS. Nature Protocols. 8(6). 1155–1168. 70 indexed citations
19.
Geurink, Paul P., Bogdan I. Florea, Nan Li, et al.. (2010). A Cleavable Linker Based on the Levulinoyl Ester for Activity‐Based Protein Profiling. Angewandte Chemie. 122(38). 6954–6957. 15 indexed citations
20.
Geurink, Paul P., Bogdan I. Florea, Nan Li, et al.. (2010). A Cleavable Linker Based on the Levulinoyl Ester for Activity‐Based Protein Profiling. Angewandte Chemie International Edition. 49(38). 6802–6805. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kah‐Yee Li Breakdown of academic impact, for papers by Xu He Breakdown of academic impact, for papers by Xuequan Lu Breakdown of academic impact, for papers by Thomas Lanyon‐Hogg Breakdown of academic impact, for papers by Qing‐Xin Hua Breakdown of academic impact, for papers by Tineke Voorn-Brouwer Breakdown of academic impact, for papers by Manju Basu Breakdown of academic impact, for papers by Andrea Gunawan Breakdown of academic impact, for papers by Todd L. Graybill Breakdown of academic impact, for papers by Sybrin P. Schröder
Rankless by CCL
2026